KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy

BACKGROUND: Two previous first-line studies showed an improved trend in response rate (RR) and progression free survival (PFS) in metastatic colorectal cancer (CRC) patients with KRAS mutation. Others have reported a worsened outlook for metastatic CRC patients with KRAS mutation and a higher likeli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sharma, Neelesh, Saifo, Maher, Tamaskar, Ila R, Bhuvaneswari, Ramkumar, Mashtare, Terry, Fakih, Marwan
Formato: Artigo
Idioma:Inglês
Publicado em: Pioneer Bioscience Publishing Company 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3397582/
https://ncbi.nlm.nih.gov/pubmed/22811812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2010.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados